The article discusses Jim Cramer's investing experiences and emphasizes the importance of starting early in the stock market. It also highlights Regeneron Pharmaceuticals Inc. as a strong investment option with a solid pipeline and growth potential, ranking 16th on Cramer's list.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing